Matt Coelho
Cancer Research UK Career Development Fellow at the Wellcome Sanger Institute - gene editing - drug resistance - cancer
@nataliabrzozowska.bsky.social
Researching somatic evolution in liver disease at Wellcome Sanger Institute
@mikespencerchapman.bsky.social
Haematology doctor & researcher, UK. Interested in blood ageing, transplant, cancer and development. Lapsed musician.
@jijaz.bsky.social
Scientist in Altos Labs (aging) | Post doc in Reik lab (lineage tracing and development) | PhD in Campbell Lab (chromothripsis/structural variation in cancer)
@jtneal.bsky.social
PI @ http://neallab.org. Scientist building tools to understand genetic variation in health and disease. Trail runner & World’s Okayest Dad.
@juliosaezrod.bsky.social
Computational Biologist, Head of research @ebi.embl.org, part-time Heidelberg University, codirector DREAM challenges. For group's activities, see @saezlab.bsky.social
@timcoorens.bsky.social
Incoming Group Leader EMBL-EBI | Postdoc at Broad Institute | PhD at Sanger Institute | Lineage tracing, cancer genomics, human development
@sangerinstitute.bsky.social
We are a world leader in genomics research. We apply and explore genomic technologies to advance the understanding of biology and improve health 🧬 https://www.sanger.ac.uk/
@jhepkema.bsky.social
PhD student at Sanger Institute in Parts & Stegle labs. Interested in anything related to gene regulation! https://jacobhepkema.github.io
@diefenbacherlab.bsky.social
Targeting protein stability in #Cancer via #Ubiquitin-System @HelmholtzMunich @LungHealthMUC and @LMU_Muenchen Impressum: http://www.diefenbacher-lab.com/Impressum/ http://www.diefenbacher-lab.com/ https://www.helmholtz-munich.de/en/environmental-health-ce
@ryandchow.bsky.social
IM resident at Penn || 2023 MD/PhD at Yale with Sidi Chen || 2016 undergrad Harvard with Jay Rajagopal. https://www.ryanchow.org/
@mirjana-efremova.bsky.social
Group leader at the Barts Cancer Institute, investigating non-genetic mechanisms of metastasis and therapy resistance
@ruoyanli89.bsky.social
Assistant Professor at MD Anderson Cancer Center | Cancer genomics, single-cell genomics, and somatic evolution https://www.mdanderson.org/research/departments-labs-institutes/labs/ruoyan-li-laboratory.html
@fritzroth.bsky.social
Opinions here are my own. Day job: Professor and Chair, Computational & Systems Biology, University of Pittsburgh School of Medicine https://rothlab.csb.pitt.edu/ Systematically testing impacts of genetic change & mapping protein interaction dynamics
@luigiombrato.bsky.social
Metastatic Niche Lab @bci.bsky.social. Studying the role of Tumour Microenvironment in Metastasis formation. @cancerresearchuk.org fellow. Previously @CRG.eu and @Tigem_Telethon
@opentargets.org
Public-private partnership using human genetics and genomics data for systematic drug target identification and prioritisation. http://blog.opentargets.org
@atjcagan.bsky.social
Researching somatic evolution at the University of Cambridge and Wellcome Sanger Institute. Also a scientific illustrator.
@lisakoob.bsky.social
@moezdawood.bsky.social
@christophertape.bsky.social
Group Leader, UCL Cancer Institute. Studying how different cell-types collaborate to drive cancer | http://tape-lab.com
@gregfindlay.bsky.social
Group Leader The Genome Function Laboratory The Francis Crick Institute, London
@peeperlab.bsky.social
Cancer researcher @NKI_nl and @oncodeinstitute, Cofounder of Flindr Tx; developing rational cancer & immune cell combination treatments using functional genomics
@molinaarcas.bsky.social
Cancer cell biologist at the Francis Crick Institute. KRAS enthusiast
@charlesswanton.bsky.social
Cancer Evolution and Genome Instability Lab Francis Crick Institute. Views my own
@gabrielepicco.bsky.social
Senior Staff Scientist @sangerinstitute. Passionate about cancer genetics, functional genomics and precision medicine. Husband of one. Daddy of two.
@r-rahbari.bsky.social
Group Leader @Wellcome Sanger Institute. @CRUK fellow | Interested in mutations acquired during aging and their impact across generation.
@muffley.bsky.social
Director of Program Operations (Variant Effects Portfolio) CMAP, CAVA and the Atlas of Variant Effects Alliance | she/her 🏳️🌈 https://fowlerlab.gs.washington.edu/people https://brotmanbaty.org/research/atlas-of-variant-effects
@nevillesanjana.bsky.social
Scientist at the New York Genome Center & NYU. http://sanjanalab.org
@landau.bsky.social
Oncologist-scientist at Weill Cornell and New York genome center. Into somatic evolution, trees and words
@fabiantheis.bsky.social
Computational biologist @HelmholtzMunich, prof @TU_Muenchen & associate PI @sangerinstitute. Dad of 4 and mountain lover. Department news, see @CompHealthMuc
@boehmjesse.bsky.social
Chief Science Officer, Break Through Cancer; Principal Investigator, Koch Institute, MIT - boehmlab.org
@natbiotech.nature.com
Publishing the best of biotech science and business. Part of @natureportfolio.bsky.social. Find us on Twitter, Facebook & Instagram.
@mattneville.bsky.social
Postdoctoral scientist @ Sanger Institute in Cambridge, UK. Sperm sequencing, de novo mutation, and somatic evolution.
@vanallenlab.bsky.social
Clinical Computational Oncology @DanaFarber @harvardmed @broadinstitute | Chief - Population Sciences | Prev.: @Stanford @UCLA @UCSF | Discl.: http://bit.ly/2kF9C7B
@vanessafburns.bsky.social
PhD Candidate in Human Genetics, Wellcome Sanger Institute | University of Cambridge Volunteer Writer for BioNews, Progress Educational Trust (PET)
@itaiyanai.bsky.social
Professor at the NYU School of Medicine (https://yanailab.org/). Co-host of the 'Night Science Podcast' https://podcasts.apple.com/us/podcast/night-science/id1563415749
@crukcamcentre.bsky.social
Cancer centre uniting over 1200 experts to tackle cancer from every angle. A partnership between Cancer Research UK, the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. crukcambridgecentre.org.uk
@andreasbender.bsky.social
Cheminformatics, bioinformatics, drug discovery, computational life sciences etc - for more information please see https://andreasbender.de Proud editor of the 'Cambridge Cheminformatics Newsletter' - please see https://www.drugdiscovery.net
@ebos.bsky.social
Associate Prof. in Cancer Genetics at Roswell Park Comprehensive Cancer Center studying drug resistance, metastasis, the tumor microenvironment, immunecheckpoints, and angiogenesis. https://www.roswellpark.org/research/labs/ebos-lab
@emanuelvgo.bsky.social
Assistant Professor Instituto Superior Técnico (IST) and INESC-ID https://web.tecnico.ulisboa.pt/emanuel.v.goncalves/
@nlbigas.bsky.social
ICREA Research Professor at IRB Barcelona. Working on computational cancer genomics. Leading @bbglab.bsky.social http://bbglab.irbbarcelona.org Currently in San Francisco. Visiting scholar at @ucsfcancer.bsky.social
@lizziecoker.bsky.social
Cambridge-based data scientist modelling drug combinations to improve patient outcomes. Views my own, she/her 🇪🇺
@lapassmore.bsky.social
Molecular biologist. Group leader at MRC LMB Cambridge UK. Fellow at Clare Hall college. #CryoEM #RNAbiology #DNArepair Views/opinions are my own. https://www2.mrc-lmb.cam.ac.uk/group-leaders/n-to-s/lori-passmore/
@kevinng.bsky.social
Schmidt Science Fellow at Rockefeller University. B cells, cancer, and endogenous retroviruses. Part-time music critic, semi-retired violinist.
@klausokken.bsky.social
Professor of Immunology, Department of Pathology, University of Cambridge. Research interests: PI3K, immunity, infection, cancer, immunotherapy.
@cruk-si.bsky.social
Cancer Research UK Scotland Institute (formerly the CRUK Beatson Institute). Our Mission: Cancer discovery for patient benefit. www.crukscotlandinstitute.ac.uk